Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Gallelli, L.; Terracciano, R.; Vatrella, A.
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. Int. J. Mol. Sci. 2021, 22, 4369.
https://doi.org/10.3390/ijms22094369
AMA Style
Pelaia C, Pelaia G, Crimi C, Maglio A, Gallelli L, Terracciano R, Vatrella A.
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. International Journal of Molecular Sciences. 2021; 22(9):4369.
https://doi.org/10.3390/ijms22094369
Chicago/Turabian Style
Pelaia, Corrado, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Luca Gallelli, Rosa Terracciano, and Alessandro Vatrella.
2021. "Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma" International Journal of Molecular Sciences 22, no. 9: 4369.
https://doi.org/10.3390/ijms22094369
APA Style
Pelaia, C., Pelaia, G., Crimi, C., Maglio, A., Gallelli, L., Terracciano, R., & Vatrella, A.
(2021). Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. International Journal of Molecular Sciences, 22(9), 4369.
https://doi.org/10.3390/ijms22094369